Stryker (SYK) Change in Accured Expenses (2009 - 2026)
Stryker (SYK) reported Change in Accured Expenses of -$654.0 million for Q1 2026, down 29.76% year-over-year from -$931.1 million in Q1 2025, and down 265.15% quarter-over-quarter from $396.0 million in Q4 2025.
Stryker (SYK) Change in Accured Expenses (2009 - 2026) Analysis & Trends
Stryker (SYK) has 18 years of Change in Accured Expenses data on file, last reported at -$654.0 million in Q1 2026.
- Change in Accured Expenses for Q1 2026 came in at -$654.0 million, down 29.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $168.0 million (down 18.05% YoY), and the FY2025 annual result was $318.0 million, up 329.73% from the prior year.
- Change in Accured Expenses declined to -$654.0 million in Q1 2026 per SYK's latest filing, from $396.0 million in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $429.0 million in Q3 2024 and troughed at -$654.0 million in Q1 2026.
- A 5-year average of $24.1 million and a median of $151.0 million in 2022 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2024 and 2025: Change in Accured Expenses plunged 107.5% in 2024, then surged 2255.56% in 2025.
- A 5-year view of Change in Accured Expenses shows it stood at $151.0 million in 2022, then soared by 143.05% to $367.0 million in 2023, then dropped by 18.8% to $298.0 million in 2024, then soared by 32.89% to $396.0 million in 2025, then plunged by 265.15% to -$654.0 million in 2026.
- Business Quant data shows SYK's Change in Accured Expenses at -$654.0 million in Q1 2026, $396.0 million in Q4 2025, and $38.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 703.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 21.07 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 145.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 74.30 Mn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | -183.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -654.00 Mn |
| Mar 31, 2026 | -654.00 Mn |
| Dec 31, 2025 | 396.00 Mn |
| Dec 31, 2025 | 396.00 Mn |
| Sep 30, 2025 | 38.00 Mn |
| Sep 30, 2025 | 38.00 Mn |
| Jun 30, 2025 | 388.00 Mn |
| Jun 30, 2025 | 388.00 Mn |
| Mar 31, 2025 | -504.00 Mn |
| Mar 31, 2025 | -504.00 Mn |
| Dec 31, 2024 | 298.00 Mn |
| Dec 31, 2024 | 298.00 Mn |
| Sep 30, 2024 | 429.00 Mn |
| Sep 30, 2024 | 429.00 Mn |
| Jun 30, 2024 | -18.00 Mn |
| Jun 30, 2024 | -18.00 Mn |
| Mar 31, 2024 | -635.00 Mn |
| Mar 31, 2024 | -635.00 Mn |
| Dec 31, 2023 | 367.00 Mn |
| Dec 31, 2023 | 367.00 Mn |